Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Maximizing Outcomes in Treating Acute Migraine

ClinicalTrials.gov ID: NCT03896009

Public ClinicalTrials.gov record NCT03896009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MOMENTUM: A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults. AXS-07 tablets are formulated to provide an enhanced rate of absorption of meloxicam. This study is designed to evaluate the efficacy and safety of AXS-07 compared to meloxicam, rizatriptan, and placebo for the treatment of a migraine attack. This is a randomized, double-blind, 4-arm, parallel group, single-dose, placebo-controlled trial. Subjects who successfully complete screening and continue to meet all entry criteria will be randomly assigned to take one dose of either AXS-07, meloxicam, rizatriptan, or placebo upon the occurrence of a qualifying migraine.

Study identification

NCT ID
NCT03896009
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
1,594 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2019 (Actual)
Primary completion
Dec 10, 2019 (Actual)
Completion
Dec 10, 2019 (Actual)
Last update posted
Aug 24, 2023

2019

United States locations

U.S. sites
85
U.S. states
31
U.S. cities
83
Facility City State ZIP Site status
Clinical Research Site Birmingham Alabama 35205 —
Clinical Research Site Birmingham Alabama 35216 —
Clinical Research Site Mobile Alabama 36608 —
Clinical Research Site Phoenix Arizona 85004 —
Clinical Research Site Tempe Arizona 85283 —
Clinical Research Site Little Rock Arkansas 72209 —
Clinical Research Site Canoga Park California 91303 —
Clinical Research Site Colton California 92399 —
Clinical Research Site Culver City California 90230 —
Clinical Research Site Encino California 91316 —
Clinical Research Site Los Alamitos California 90720 —
Clinical Research Site Los Angeles California 90017 —
Clinical Research Site Oceanside California 92506 —
Clinical Research Site Pomona California 91767 —
Clinical Research Site Redlands California 92374 —
Clinical Research Site Riverside California 92503 —
Clinical Research Site San Diego California 92103 —
Clinical Research Site Santa Monica California 90404 —
Clinical Research Site Spring Valley California 91978 —
Clinical Research Site Walnut Creek California 94598 —
Clinical Research Site Waterbury Connecticut 06708 —
Clinical Research Site Clermont Florida 34711 —
Clinical Research Site DeLand Florida 32720 —
Clinical Research Site Fernandina Beach Florida 32034 —
Clinical Research Site Hallandale Florida 33009 —
Clinical Research Site Hialeah Florida 33012 —
Clinical Research Site Hollywood Florida 33024 —
Clinical Research Site Jacksonville Florida 32256 —
Clinical Research Site Lake City Florida 32055 —
Clinical Research Site Lake Worth Florida 33467 —
Clinical Research Site Miami Florida 33155 —
Clinical Research Site Ocoee Florida 34761 —
Clinical Research Site Orange City Florida 32763 —
Clinical Research Site Orlando Florida 32801 —
Clinical Research Site Ormond Beach Florida 32174 —
Clinical Research Site South Miami Florida 33143 —
Clinical Research Site Sunrise Florida 33351 —
Clinical Research Site Tampa Florida 33634 —
Clinical Research Site Atlanta Georgia 30312 —
Clinical Research Site Atlanta Georgia 30331 —
Clinical Research Site Stockbridge Georgia 30281 —
Clinical Research Site Meridian Idaho 83642 —
Clinical Research Site Evanston Illinois 60201 —
Clinical Research Site Lenexa Kansas 66214 —
Clinical Research Site Lexington Kentucky 40509 —
Clinical Research Site Louisville Kentucky 40213 —
Clinical Research Site New Orleans Louisiana 70125 —
Clinical Research Site Boston Massachusetts 02131 —
Clinical Research Site North Dartmouth Massachusetts 02747 —
Clinical Research Site Watertown Massachusetts 02472 —
Clinical Research Site Ann Arbor Michigan 48104 —
Clinical Research Site Minneapolis Minnesota 55402 —
Clinical Research Site Kansas City Missouri 64114 —
Clinical Research Site Springfield Missouri 65810 —
Clinical Research Site Las Vegas Nevada 89102 —
Clinical Research Site Berlin New Jersey 08009 —
Clinical Research Site Toms River New Jersey 08755 —
Clinical Research Site Albuquerque New Mexico 87102 —
Clinical Research Site Endwell New York 12760 —
Clinical Research Site Manlius New York 13104 —
Clinical Research Site New York New York 10017 —
Clinical Research Site Rochester New York 14609 —
Clinical Research Site The Bronx New York 10461 —
Clinical Research Site Williamsville New York 14221 —
Clinical Research Site High Point North Carolina 27262 —
Clinical Research Site Wilmington North Carolina 24801 —
Clinical Research Site Cincinnati Ohio 45212 —
Clinical Research Site Cleveland Ohio 44122 —
Clinical Research Site Dublin Ohio 43016 —
Clinical Research Site Oklahoma City Oklahoma 73106 —
Clinical Research Site Portland Oregon 97214 —
Clinical Research Site Salem Oregon 97301 —
Clinical Research Site Philadelphia Pennsylvania 19114 —
Clinical Research Site Charleston South Carolina 29406 —
Clinical Research Site Mt. Pleasant South Carolina 29464 —
Clinical Research Site Knoxville Tennessee 37920 —
Clinical Research Site Memphis Tennessee 38119 —
Clinical Research Site Nashville Tennessee 37203 —
Clinical Research Site Austin Texas 78731 —
Clinical Research Site San Antonio Texas 78229 —
Clinical Research Site Salt Lake City Utah 84107 —
Clinical Research Site Charlottesville Virginia 22911 —
Clinical Research Site Norfolk Virginia 23507 —
Clinical Research Site Bellevue Washington 98007 —
Clinical Research Site Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03896009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03896009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →